Efficacy and safety of KL-A167 in previously treated recurrent or metastatic nasopharyngeal carcinoma: a multicenter, single-arm, phase 2 study
Author(s) -
Yuankai Shi,
Xintian Qin,
Xingchen Peng,
Aiping Zeng,
Jingao Li,
Chuanben Chen,
Sufang Qiu,
Suming Pan,
Yulong Zheng,
Jing Cai,
Chen Xiao-pin,
Shenhong Qu,
Lizhu Lin,
Jian-Li Huang,
Hui Wu,
Ying Lu,
Wei Wang,
Changlu Hu,
Xia He,
Zhong-Hua Yu,
Xiaojian Liu,
Bo Xie,
Anwen Liu,
Guangyuan Hu,
Shanghua Jing,
Qingyuan Zhang,
Renhua Guo,
Qi Li,
Jinsheng Hong,
Feng Jin,
Juan Meng,
Jianhua Shi,
Peiguo Wang,
Jiuwei Cui,
Kunyu Yang,
Xuebang Zhang,
Xiaojiang Li,
Liangfang Shen,
Yuxiang He,
Limin Zhai,
Xiuhua Sun,
Junyou Ge,
Yan Qing,
Dekang Zong
Publication year - 2022
Publication title -
the lancet regional health - western pacific
Language(s) - English
Resource type - Journals
ISSN - 2666-6065
DOI - 10.1016/j.lanwpc.2022.100617
Subject(s) - medicine , nasopharyngeal carcinoma , clinical endpoint , phases of clinical research , population , gastroenterology , progression free survival , surgery , adverse effect , oncology , chemotherapy , clinical trial , radiation therapy , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom